<?xml version="1.0" encoding="UTF-8"?><feed xmlns="https://www.w3.org/2005/Atom" xml:lang="it"><title type="text">pillole.org</title><subtitle type="text">Pillole di medicina telematica info professionali mediche</subtitle><id>https://www.pillole.org/public/aspnuke/news.asp</id><link rel="alternate" type="application/xhtml+xml" href="https://www.pillole.org/"/><link rel="self" type="application/atom+xml" href="https://www.pillole.org/public/aspnuke/feedatom10multi.asp?channel=21"/><author><name>Pillole.org</name><uri>https://www.pillole.org</uri><email>info@pillole.org</email></author><rights>Copyright (c) 2005, Pillole.org</rights><updated>2026-05-14T00:00:00+01:00</updated><entry><title type="html">Colesterolo HDL: &#232; sempre buono?</title><summary type="html">Avere livelli di colesterolo HDL troppo elevati potrebbe aumentare il rischio cardiovascolare.
</summary><category term="news" scheme="https://www.pillole.org/public/aspnuke/news.asp/" label="News" /><id>https://www.pillole.org/public/aspnuke/news.asp,2026-05-14:?id=8994</id><link href="https://www.pillole.org/public/aspnuke/news.asp?id=8994" /><link rel="alternate" href="https://www.pillole.org/public/aspnuke/news.asp?id=8994" type="application/xhtml+xml" hreflang="it" /><updated>2026-05-03T06:28:00+01:00</updated></entry><entry><title type="html">AACE - Linee guida 2026 sul diabete di tipo 2</title><summary type="html">L'American Association of Clinical Endocrinology ha aggiornato le linee guida sulla gestione del diabete di tipo 2 che sostituiscono le precedenti del 2023.</summary><category term="news" scheme="https://www.pillole.org/public/aspnuke/news.asp/" label="News" /><id>https://www.pillole.org/public/aspnuke/news.asp,2026-05-14:?id=9023</id><link href="https://www.pillole.org/public/aspnuke/news.asp?id=9023" /><link rel="alternate" href="https://www.pillole.org/public/aspnuke/news.asp?id=9023" type="application/xhtml+xml" hreflang="it" /><updated>2026-04-22T18:39:00+01:00</updated></entry><entry><title type="html">Glicemia a digiuno tra 100 e 125 mg/dL: categoria diagnostica o convenzione operativa?</title><summary type="html">Riflessioni sul pre-diabete, sul rischio assoluto e sui limiti inferenziali dell'epidemiologia osservazionale nella costruzione delle soglie diagnostiche</summary><category term="news" scheme="https://www.pillole.org/public/aspnuke/news.asp/" label="News" /><id>https://www.pillole.org/public/aspnuke/news.asp,2026-05-14:?id=8996</id><link href="https://www.pillole.org/public/aspnuke/news.asp?id=8996" /><link rel="alternate" href="https://www.pillole.org/public/aspnuke/news.asp?id=8996" type="application/xhtml+xml" hreflang="it" /><updated>2026-04-12T06:28:00+01:00</updated></entry><entry><title type="html">La &quot;piramide rovesciata&quot; dell'alimentazione - Parte quinta</title><summary type="html">Cosa dicono e perch&#232; hanno suscitato un ampio dibattito le nuove linee guida americane sulla corretta alimentazione.

</summary><category term="news" scheme="https://www.pillole.org/public/aspnuke/news.asp/" label="News" /><id>https://www.pillole.org/public/aspnuke/news.asp,2026-05-14:?id=8995</id><link href="https://www.pillole.org/public/aspnuke/news.asp?id=8995" /><link rel="alternate" href="https://www.pillole.org/public/aspnuke/news.asp?id=8995" type="application/xhtml+xml" hreflang="it" /><updated>2026-04-05T06:28:00+01:00</updated></entry><entry><title type="html">La &quot;piramide rovesciata&quot; dell'alimentazione - Parte quarta</title><summary type="html">Cosa dicono e perch&#232; hanno suscitato un ampio dibattito le nuove linee guida americane sulla corretta alimentazione.
</summary><category term="news" scheme="https://www.pillole.org/public/aspnuke/news.asp/" label="News" /><id>https://www.pillole.org/public/aspnuke/news.asp,2026-05-14:?id=8989</id><link href="https://www.pillole.org/public/aspnuke/news.asp?id=8989" /><link rel="alternate" href="https://www.pillole.org/public/aspnuke/news.asp?id=8989" type="application/xhtml+xml" hreflang="it" /><updated>2026-03-29T06:28:00+01:00</updated></entry><entry><title type="html">La &quot;piramide rovesciata&quot; dell'alimentazione - Parte terza</title><summary type="html">Cosa dicono e perch&#232; hanno suscitato un ampio dibattito le nuove linee guida americane sulla corretta alimentazione.

</summary><category term="news" scheme="https://www.pillole.org/public/aspnuke/news.asp/" label="News" /><id>https://www.pillole.org/public/aspnuke/news.asp,2026-05-14:?id=8981</id><link href="https://www.pillole.org/public/aspnuke/news.asp?id=8981" /><link rel="alternate" href="https://www.pillole.org/public/aspnuke/news.asp?id=8981" type="application/xhtml+xml" hreflang="it" /><updated>2026-03-22T06:28:00+01:00</updated></entry><entry><title type="html">La &quot;piramide rovesciata&quot; dell'alimentazione - Parte seconda</title><summary type="html">Cosa dicono e perch&#232; hanno suscitato un ampio dibattito le nuove linee guida americane sulla corretta alimentazione.
</summary><category term="news" scheme="https://www.pillole.org/public/aspnuke/news.asp/" label="News" /><id>https://www.pillole.org/public/aspnuke/news.asp,2026-05-14:?id=8972</id><link href="https://www.pillole.org/public/aspnuke/news.asp?id=8972" /><link rel="alternate" href="https://www.pillole.org/public/aspnuke/news.asp?id=8972" type="application/xhtml+xml" hreflang="it" /><updated>2026-03-15T06:28:00+01:00</updated></entry><entry><title type="html">La &quot;piramide rovesciata&quot; dell'alimentazione - Parte prima</title><summary type="html">Cosa dicono e perch&#232; hanno suscitato un ampio dibattito le nuove linee guida americane sulla corretta alimentazione.</summary><category term="news" scheme="https://www.pillole.org/public/aspnuke/news.asp/" label="News" /><id>https://www.pillole.org/public/aspnuke/news.asp,2026-05-14:?id=8969</id><link href="https://www.pillole.org/public/aspnuke/news.asp?id=8969" /><link rel="alternate" href="https://www.pillole.org/public/aspnuke/news.asp?id=8969" type="application/xhtml+xml" hreflang="it" /><updated>2026-03-08T06:28:00+01:00</updated></entry><entry><title type="html">Cosa succede quando si smettono i farmaci per l'obesit&#224;?</title><summary type="html">Una metanalisi dimostra che i farmaci per perdere peso, compresi i pi&#249; recenti agonisti del recettore GLP-1, sono efficaci ma alla loro sospensione il peso tende a tornare a livello di quello di partenza in meno di 2 anni.</summary><category term="news" scheme="https://www.pillole.org/public/aspnuke/news.asp/" label="News" /><id>https://www.pillole.org/public/aspnuke/news.asp,2026-05-14:?id=8935</id><link href="https://www.pillole.org/public/aspnuke/news.asp?id=8935" /><link rel="alternate" href="https://www.pillole.org/public/aspnuke/news.asp?id=8935" type="application/xhtml+xml" hreflang="it" /><updated>2026-02-15T06:28:00+01:00</updated></entry><entry><title type="html">Diabete di tipo 2: una linea guida &quot;vivente&quot;</title><summary type="html">Una living systematic review ha paragonato tra loro i vari trattamenti per il diabete di tipo 2 e personalizzato la terapia sulla base del profilo cardiovascolare e renale del paziente.
</summary><category term="news" scheme="https://www.pillole.org/public/aspnuke/news.asp/" label="News" /><id>https://www.pillole.org/public/aspnuke/news.asp,2026-05-14:?id=8825</id><link href="https://www.pillole.org/public/aspnuke/news.asp?id=8825" /><link rel="alternate" href="https://www.pillole.org/public/aspnuke/news.asp?id=8825" type="application/xhtml+xml" hreflang="it" /><updated>2025-10-26T06:28:00+01:00</updated></entry></feed>